This item is non-discoverable
KMUi-Biomedizin-1: Entwicklung allosterischer Inhibitoren für das Onkologie Phosphatase Target ANV3 (ANAVOTX-ANV3)
BMBF: KMU-innovativ: Biomedizin - Sachbericht zum Verwendungsnachweis
| dc.contributor.author | Zech, Birgit | |
| dc.contributor.author | Dreyer-Lamm, Jacqueline | |
| dc.date.accessioned | 2025-11-12T10:39:32Z | |
| dc.date.available | 2025-11-12T10:39:32Z | |
| dc.date.issued | 2025-10-31 | |
| dc.description.abstract | Alte, unvollständige Version. Neue Version: https://oa.tib.eu/renate/handle/123456789/33540 [no abstract available] | |
| dc.description.version | publishedVersion | |
| dc.identifier.uri | https://oa.tib.eu/renate/handle/123456789/25407 | |
| dc.identifier.uri | https://doi.org/10.34657/24424 | |
| dc.language.iso | ger | |
| dc.publisher | Hannover : Technische Informationsbibliothek | |
| dc.relation.affiliation | Anavo Therapeutics GmbH | |
| dc.rights.license | Creative Commons Attribution-NonDerivs 3.0 Germany | |
| dc.rights.uri | https://creativecommons.org/licenses/by-nd/3.0/de/ | |
| dc.subject.ddc | 500 | Naturwissenschaften | |
| dc.subject.other | Phosphatase | ger |
| dc.subject.other | allosterische Inhibitoren | ger |
| dc.title | KMUi-Biomedizin-1: Entwicklung allosterischer Inhibitoren für das Onkologie Phosphatase Target ANV3 (ANAVOTX-ANV3) | ger |
| dc.title.subtitle | BMBF: KMU-innovativ: Biomedizin - Sachbericht zum Verwendungsnachweis | |
| dc.type | Report | |
| dcterms.event.date | 01.05.2023-30.04.2025 | |
| dcterms.extent | 14 Seiten | |
| dtf.funding.funder | BMFTR | |
| dtf.funding.program | 03LW0380 | |
| tib.accessRights | openAccess |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- ANAVOTX-ANV3_Schlussbericht_FKZ03LW0380.pdf
- Size:
- 572.89 KB
- Format:
- Adobe Portable Document Format
- Description: